SRKW APPOINTED AS LEAD COUNSEL IN ABBOTT-DEPAKOTE DERIVATIVE LITIGATION

The District Court for the Northern District of Illinois appointed SRKW as lead counsel in a shareholder derivative action against the Board of Directors of Abbott Laboratories. While notably singling out the quality of SRKW's complaint, the Court underscored that SRKW demonstrated additional dynamism by obtaining critical materials from the FDA. SRKW has prosecuted Abbott in the past for other violations. Indeed, a 1999 derivative action led by SRKW resulted in a positive legal decision by the Seventh Circuit Court of Appeals and a settlement that gave way to material corporate governance reforms.